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a b s t r a c t
The process of obtaining informed consent for school-based adolescent immunisation provides an oppor-
tunity to engage families. However, the fact that parental consent needs to be obtained remotely adds
complexity to the process and can have a detrimental effect on vaccine uptake. We conducted a multiple
methods analysis to examine the practice of obtaining informed consent in adolescent immunisation pro-
grammes. This involved a thematic analysis of consent related data from 39 interviews with immunisa-
tion managers and providers collected as part of a 2017 service evaluation of the English adolescent girls’
HPV vaccine programme and a descriptive statistical analysis of data from questions related to consent
included in a 2017 survey of parents’ and adolescents’ attitudes to adolescent vaccination. The findings
indicated that the non-return of consent forms was a significant logistical challenge for immunisation
teams, and some were piloting opt-out consent mechanisms, increasing the proportion of adolescents
consenting for their own immunisations, and introducing electronic consent. Communicating vaccine
related information to parents and schools and managing uncertainties about obtaining adolescent
self-consent for vaccination were the main practical challenges encountered. Survey data showed that
parents and adolescents generally agreed on vaccine decisions although only 32% of parents discussed
vaccination with their teenager. Parental awareness about the option for adolescents to self-consent
for vaccination was limited and adolescents favoured leaving the decision-making to parents. From the
interviews and variability of consent forms it was evident that health professionals were not always clear
about the best way to manage the consent process. Some were also unfamiliar with self-consent pro-
cesses and lacked confidence in assessing for ‘Gillick competency’. Developing pathways and related
interventions to improve the logistics and practice of consent in school-based adolescent immunisation
programmes could help improve uptake.
 2019 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The number of routine vaccinations offered to adolescents has
increased in recent years. In England, three vaccines are offered
through schools (HPV, Men ACWY and DTP booster - see Table 1)
[1], which has proved to be effective in achieving high coverage
and efficient delivery to larger cohorts in a short time period. The
school-based delivery model is used in a wide range of other set-
tings and is being assessed for the United States adolescent immu-
nisation programme [2]. Pupils who are absent can be followed up
in catch-up sessions at schools, community clinics and primary
care. Although school-based vaccination is well accepted by par-
ents and students [3], it entails logistical challenges including the
return of parental consent forms, which can be a barrier to achiev-
ing higher coverage [4,5].
1.1. Informed consent & adolescent immunisation
The World Health Organization (WHO) defines an adolescent as
any person aged 10–19 [6] and categorises current vaccination
consent practice for 6–17 year olds in three ways [7]:
(1) Written consent – parent/guardian complete form to give
consent
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(2) Verbal consent – parent/guardian give verbal consent after
being informed
(3) Implied consent – (opt-out) the choice to refuse consent
1.1.1. Models for obtaining informed consent
In England, consent for adolescent immunisation programmes
is mainly obtained from legal guardians (usually parents). Young
people are given a form for their parent to sign and hand back to
school before an immunisation session takes place. However, a
proportion of consent forms are not returned [8,9], which has
implications for vaccine uptake. Achieving high rates of consent
is dependent on persistent efforts by schools and immunisation
teams to follow up missing forms [4,9,10]. The following
resource-intensive strategies have been shown to help improve
vaccine uptake: supplementing the distribution of paper consent
forms with phone calls to parents, incentivising form returns and
offering additional opportunities for catch-up [4,10–13]. Several
countries are piloting or using other consent models, such as a
streamlined universal consent form which parents complete to
indicate approval for all immunisations provided at secondary
school [14], and default policies [15]. Initial results indicate that
parents prefer opt-in systems [15], and want timely information
about vaccines given at different stages during a student’s time
at school [14].
1.1.2. Adolescent self-consent
The age at which adolescents can self-consent for vaccination
varies across different contexts and differs from assent, which is
when young people are involved in decision-making but do not
make an autonomous decision. In England, increased support is
being given to the practice of adolescent self-consent, not only
for Men ACWY and booster vaccines given to older adolescents
(14–16 years) but also for HPV vaccine given from age 12 onwards.
In these instances, the role of the health professional is to assess
the young person’s maturity and understanding of the vaccination
programme and judge whether they are ‘Gillick competent’ i.e. able
to consent to vaccination by themselves [16–18]. Previous research
suggests that the implementation of adolescent self-consent proce-
dures can be problematic with many nurses tending to delay vac-
cination rather than vaccinate without parental consent [5,19].
Situations where daughters and parents disagree about the deci-
sion to vaccinate can be particularly difficult to manage - especially
in school-based programmes, where overriding parents’ wishes
can have a detrimental effect on the relationship between school
and parents [20].
1.1.3. Communication & informed consent
It is evident that communication is core to ensuring that par-
ents and adolescents are in a position to make informed decisions
about vaccination. Gottvall et al. [21] highlight the importance of
adopting a ‘relational approach’ to obtaining informed consent.
This approach recognises that individuals are interdependent and
embedded within social contexts (e.g. families and peer groups)
which need to be accounted for in communication strategies. This
is not straightforward in school-based immunisation programmes,
where health professionals have limited opportunities for face to
face interaction with parents and to some extent adolescents. They
have to work very closely with schools to promote informed and
positive discussion about adolescent immunisation across the
school and the home context.
2. Aim and methods
This research investigated the process by which consent is
obtained in the English school-based adolescent immunisation
programme with the aim of understanding existing challenges
and identifying pathways for optimising the consent processes.
To do this we have combined data from two sources: (1) interviews
with immunisation providers/managers and a review of consent
forms, (2) analysis of survey data of parents and adolescents in
relation to vaccination attitudes. The methods used to collect this
data are described in the following sections.
2.1. HPV vaccine programme service evaluation
In 2017, we conducted a service evaluation to identify service-
related factors which may have contributed to a small decline in
HPV vaccine coverage in adolescent girls in England. This decline
occurred following the change from a three to a two-dose schedule
in 2014 and resulted in completion rates dropping from 86.7% for
the three dose course in 2013/14 to 85.1% and 83% for the of
two-dose course in 2015/16 and 2016/17 respectively [22,23].
The service evaluation involved conducting semi-structured
interviews with 39 participants responsible for delivering immu-
nization programmes in six local authorities in the South West
(Cornwall, North Somerset, Bristol), North Central Midlands (Lin-
colnshire, Leicester), and South Central Midlands (Luton). This
sampling frame included areas that; (i) delivered both doses of
HPV vaccine in school Year 8 and areas that delivered the first dose
in Year 8 and the second dose in Year 9. (ii) were geographically
and socio-demographically diverse, (iii) had a range of HPV cover-
age rates, and commissioned different types of providers (e.g.
school nurses, and immunization teams). A more detailed descrip-
tion of the methods and overall findings has been published else-
where [24].
As part of the service evaluation, we also conducted a content
evaluation of a sample of adolescent consent forms. We contacted
all NHS England local teams in January 2018 (n = 14) requesting
copies of the consent forms used by all their service providers in
the school-based adolescent vaccination programmes (HPV pro-
gramme, Men ACWY programme, teenage booster (Td/IPV) pro-
gramme). We received 36 consent forms for the HPV programme
and 35 consent forms for Men ACWY and teenage booster pro-
grammes. We extracted data for analysis into Microsoft Excel
and reviewed all the consent forms via a content analysis.
2.2. Adolescent tracking survey
In 2017 PHE commissioned a survey to explore the attitudes of
parents and young people to adolescent vaccines. One objective of
Table 1
Vaccinations offered routinely to adolescents in England.
Age and gender Target diseases Vaccines
Girls aged 12–13
(1st dose school in year 8)*
Cervical cancer caused by human papilloma virus (HPV) types 16 &18 and genital
warts caused by types 6 and 11
HPV Vaccine
2 doses 6–24 months apart
Girls & boys aged 14–15
(School year 9)
Tetanus, diphtheria and polio (a check of MMR status is also made) Td/IPV (one booster dose)
MMR if required (one dose)
Meningitis caused by serogroups A, C, W and Y Men ACWY (one dose)
* The HPV vaccination programme is due to be extended to boys in September 2019.
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the survey was to understand the decision-making and consent
process. Interviews were carried out in 143 randomly selected
areas in England, which were stratified by the index of multiple
deprivation. The sample of 654 parents and 652 young people
was representative of England, within each region, by deprivation,
as well as by the age and gender of young people aged 13–15. The
majority of interviews with parents and young people took place
the same household. Interviews were conducted face-to-face by
trained interviewers using Computer Assisted Personal Interview-
ing. The questions relating to the consent process included: who
makes the decision (parent, adolescent or both), whether the
immunisation decision was automatic or discussed and explored,
and whether there was ever disagreement between the parent
and young person.
3. Findings
3.1. Logistics of sending and retrieving consent forms
The dissemination and retrieval of consent forms was reported
as logistically complex and resource intensive for immunisation
teams. The main challenge was handling the non-return of forms,
which could not be recorded as ‘positive refusal’ or ‘positive consent’.
Form non-return was mainly explained as a bureaucratic failure,
although several interviewees suggested that some adolescents
may purposely not give forms to their parents. In the absence of
returned forms, nurses could not be sure that parents were aware
that their daughters have had an offer of HPV vaccine.
‘‘So, the number of non-returns is our biggest problem. We can deal
with refusals because we can evidence those, but what we can’t
determine is out of those non-returns, how many people want to
have it and how many people don’t.” (NCM, Service provider 2)
Service providers worked closely with schools to re-issue con-
sent forms and send email or text reminders to non-responders.
The active involvement of schools and nominated school staff
who supported the programme was described as critical to
increase consent form return rates. Other solutions included email-
ing parents and asking them to print out and return consent forms,
parents consenting by emails and setting up electronic consent
systems.
One area was piloting an opt-out approach for the school boos-
ter and the meningitis vaccines on the basis that most students had
already taken up the primary course for these vaccines. Parents
were informed that their children would be immunised and asked
to contact the immunisation teams if they wanted to opt-out, and
students were asked to provide verbal consent during the immuni-
sation session. Service commissioners stated that they were hesi-
tant about extending the opt-out pilot to the HPV vaccine
programme, partly because it was a vaccine offered for the first
time in adolescence but also because it targeted younger
adolescents.
3.2. Communication with parents and adolescents
The primary means of communication between immunisation
teams and parents and adolescents was by sending out invitation
letters with accompanying consent forms and in some cases an
HPV vaccine information leaflet. Some teams complemented this
with immunisation information sessions in schools for pupils,
but none offered anything similar for parents. Parents were pro-
vided with contact details for the immunisation teams so they
could ask questions and obtain more information.
‘‘. . .we’re [immunisation team] quite happy to take calls at any
point, to answer any queries. Because I have had a few [parents]
that have been thinking they’re going to say no, but then we’ve
had a conversation and it’s actually allayed their fears and it’s been
understood more clearly that they actually go ‘okay, yes, we’ll have
it’ which is good, because, as I say, we want to encourage them all
to have it. So, anything we can do to improve that is time well-
spent as far as I’m concerned.” (NCM, Service provider, 4)
According to service providers the most common parental con-
cern was the perception that if they agreed for their daughter to
receive the HPV vaccine, they were indirectly condoning promiscu-
ity. A few service providers also noted a decline in the uptake of the
second dose of HPV vaccine in their areas and associated this with
increased negative media coverage.
‘‘There’s a lot of negative press about it, and actually we found this
year that quite a few parents have actually withdrawn consent for
the second HPV. I think more work needs to be done by Public
Health to get that message out that actually, this vaccine is okay,
it is a good one to have, it is fine.” (SW, Immunisation team group
interview 2)
Service providers stressed the need for nurses to receive regular
training and have access to up to date information materials so
that they could be proactive in responding to questions about ado-
lescent immunisation. They also observed that awareness about
HPV vaccination had decreased over the last couple of years.
3.3. The practice of obtaining consent
Three approaches to obtaining consent were described: (i) writ-
ten consent form returned by parents and assent by adolescents
during immunisation sessions, (ii) verbal consent from parents
via phone calls during sessions, if parental consent forms were
not returned, and assent by adolescents, (iii) self-consent in ‘Gillick
competent’ adolescents, if parental consent form was not returned
and nurses were unable to contact parents during the session. Ado-
lescent self-consent required extra time and resources during
immunisation sessions and not all nurses felt confident about
assessing for ‘Gillick competency’. Several schools were also not
happy about girls aged under 16 being allowed to self-consent.
‘‘Around the issue of consent in schools, there were some issues
flagged this year in some of our schools. We were in [the school]
doing the Year 9s and some of them didn’t have consent forms.
One of the schools was very unhappy with the fact that we were
going to be self-consenting young people.” (SW, Immunisation
team group interview 1)
With regards to self-consent, nurses also needed to negotiate
situations where adolescents’ cultural heritage may inhibit their
ability to provide self-consent and where parents and adolescents
disagree about consent.
‘‘The difficulty is where you get a cultural mix about who makes
decisions in the house /family. This is a learning point of who makes
decisions in the family, who gives consent and obviously in certain
cultures the young person themselves wouldn’t feel able to give
consent to themselves because it would be deemed it’s their par-
ents’ responsibility and they wouldn’t obviously go against a par-
ent’s wishes.” (NCM, Service provider 2)
In situations where an adolescent did not want to be immu-
nised, nurses would ‘go with the young person’ even if parents
had provided consent. In cases where it was evident that the stu-
dent was fearful, they would book a clinic appointment, and in
cases where students provided a clear rationale for not wanting
to be immunised, they would respect their wishes and advise them
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to get back in contact if they changed their minds. Clinic mop-up
sessions were viewed as better places than schools for allaying
fears and addressing individual needs.
Managing situations where the young person wanted to be vac-
cinated but the parents disagreed was more complicated, and the
nurses in our sample often advised these students to talk to their
parents and then approach the team again when the immunisation
team returned for the next set of adolescent vaccinations.
The consent forms content analysis revealed that consent forms
varied greatly in their length and content (see supplementary files
for full details). Many included non-specific and open-ended ques-
tions about adolescents’ medical history, which were not based on
contraindications for the vaccine in question. A few forms also
asked about pregnancy even though the national guidelines were
clear that this is not required and several mentioned that ‘‘vaccina-
tions are not normally given in pregnancy”, which was inconsistent
with ongoing maternal immunisation programmes. Of relevance to
vaccine communication, less than half of the forms signposted par-
ents to information sources and many did not encourage parents to
discuss the vaccination programme with their teenager.
3.4. Consistency of parental and adolescent decision-making
The tracking survey showed that there was rarely any disagree-
ment between young people and their parents over immunisation
decisions. Only five per cent (25/498) of parents reported that they
wanted their child to have an immunisation that the young person
did not want. Only 1% (5/480) of young people wanted to have an
immunisation that their parent preferred them not to have. The
majority of parents (70%) said that they automatically (on receipt
of the consent form) consented for their child to be immunised,
with only a third of young people being involved in this decision-
making. If parents had previously seen a leaflet about teenage vac-
cination (leaflets suggested adolescents should talk to their parents
about vaccination), they were more likely to discuss it with their
child (39% who had seen at least one leaflet vs 32% overall).
The survey highlighted that only 37% (184/498) of parents
whose child had been offered immunisation were aware that their
adolescent had the right to make their own decision about immu-
nisation. Only 8% (40/498) of adolescents had self-consented to
vaccination with a similar number stating that they would like to
give their own permission. Over half of adolescents (58%
278/480) would prefer their parents to decide.
Figures that depict findings from the survey are included as
supplementary files.
4. Discussion
The process of obtaining informed consent for immunisation
provides opportunities for discussion and exchange of information
to enhance understanding and strengthen trust in vaccination pro-
grammes. The evidence presented in this paper suggests however
that logistical (form return) and practical (communicating infor-
mation, negotiating differences in opinion, and managing uncer-
tainties about self-consent) challenges can have a negative
impact on uptake in school-based programmes.
4.1. Logistical challenges and possible solutions
The non-return of consent forms was challenging to manage
and of concern to immunisation teams since it could mean that
adolescents were not receiving vaccines with significant health
benefits. Teams reported that input from school staff helped to
achieve high form return rates although not all schools could pro-
vide this. Additional follow up by teams on and after the day of
vaccination enhanced uptake but was resource intensive. Some
immunisation teams considered other options to improve form
return and vaccine uptake including opt-out (although reserva-
tions were voiced for the HPV vaccine programme due to age of
the target age-group) electronic systems and incentives. The fol-
lowing paragraphs summarise related evidence on these potential
solutions.
4.1.1. Opt-out consent models
Research on an opt-out consent model in a low and middle
income context indicated that opt-out approaches may help
achieve higher vaccine uptake rates, especially in countries like
Rwanda, where it is not usual to obtain consent prior to immunisa-
tion [25]. Research conducted in the USA however suggests that
parents prefer opt-in approaches although they were not unduly
opposed to opt-out policies [15]. A two-year service evaluation of
the opt-out pilot system for Men ACWY and DTP boosters con-
ducted in one of the evaluation case study areas concluded that:
(i) the model was feasible from a legal, financial, and parental
acceptance perspective, (ii) that it achieved higher uptake rates
in schools over 2 years (e.g. Men ACWY uptake in one school
increased by 36% in one school between 2016 and 2018), and
(iii) that it should be rolled out more widely in future [26].
4.1.2. Electronic consent systems
The development of electronic systems for obtaining consent for
immunisation is gaining momentum in England, although pub-
lished literature about the effectiveness of these systems remains
sparse. Electronic consent systems have been adopted in trials
[27] and electronic health interventions are being used to enhance
call and recall systems and deliver personalised reminders for vac-
cination appointments [28–30]. Telephone reminders have also
been shown to increase the uptake of vaccinations in school settings
[31]. Given the role technological solutions could play in improving
vaccine uptake there is a need to promote shared learning bymeans
of communities of practice [32,33] or similar learning forums.
4.1.3. Incentives
Evidence is mixed on the use of incentives to increase rates of
parental consent and the return of forms. A cluster randomised fea-
sibility trial [13] which involved the chance to win a £50 shopping
voucher in the intervention arm if girls returned consent forms
(containing a statement of agreement or refusal) showed that
87% of girls in the intervention arm returned a consent form com-
pared with 67% in the control arm. Previous research on incentives
[12,34] was less conclusive, apart from one study which found peer
incentives were more effective than individual ones [35]. Classes in
which all students returned signed forms received snack coupons.
The individual incentives were scholastic credits, school materials
(e.g. pencils and folders) and attendance at school social events.
These incentives were assessed alongside educational activities
which were found most important in motivating students to be
vaccinated [36].
4.2. Communication and vaccine-decision making
Findings from the tracking survey showed that parents and ado-
lescents generally agreed on vaccination decisions and that over
half of adolescents preferred their parents to lead in the
decision-making. Combined with evidence that showed that insuf-
ficient information about the HPV vaccine programme amongst
parents contributed to lower uptake [37], these findings emphasise
the importance of ensuring that parents are well informed about
adolescent immunisation.
The qualitative evaluation suggested that awareness about HPV
vaccination had declined over the last couple of years and that
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wider-reaching promotional activities would be helpful. The
review of consent forms also showed that there is a need to ensure
that forms refer parents and adolescents to the appropriate infor-
mation on the vaccine and avoid non-essential questions. Address-
ing informational needs is however not straightforward, however.
Streamlining consent forms by promoting the use of national tem-
plates and ensuring that these either reference or are disseminated
with information leaflets will help. Although educational pro-
grammes have been shown to increase knowledge and improve
attitudes towards specific vaccines [38–40], there is limited evi-
dence about which ones work best and whether they result in
increased uptake [40,41]. Findings from our research indicated that
it can be difficult to find time in school schedules to deliver vaccine
education. Creative educational tools like an HPV comic book
developed by Katz et al. [39] and a web-based HPV information
website [42] may help to overcome these challenges, but these
interventions require further evaluation and need to broaden their
focus to include other adolescent vaccines.
Evidence about the role of social marketing (a ‘‘process that
applies traditional marketing principles and techniques to influ-
ence target audience behaviours that benefit society as well as
the individual” [43] in promoting adolescent immunisation is also
limited. Research conducted by Cates et al. [44] assessed the effect
of HPV vaccine educational materials targeted at mothers of 11–
12 year olds which were designed using social marketing princi-
ples. They found that the educational campaign only led to modest
increases in vaccine uptake although it did spur parents to ‘take
action’ by finding out more about vaccine programmes. Another
novel approach for increasing parental and adolescent engagement
with immunisation involved forming citizen juries, which were
convened separately with adults and young people [45]. Findings
from this Australian research indicated that the two groups can
form different opinions about immunisation policies, with adoles-
cents supporting compulsory vaccination and parents preferring
opt-out systems. Of interest here is that neither of these systems
would involve active consent.
4.3. Managing self-consent
Obtaining self-consent for immunisation from teenagers has
been a longstanding good practice in circumstances where written
or verbal consent from the parent is not available at the time of
immunisation [16]. Despite this, like Wood et al. [20], we found
that health professionals were unfamiliar with the adolescent
self-consent processes and lacked confidence in how to assess for
‘Gillick competency’. Furthermore, evidence from the tracking sur-
vey suggests that parental awareness of this option is limited and
that most young people have not been offered the opportunity to
provide self-consent. This is partly explained by other survey
results which show that adolescents generally defer to parents in
immunisation decision-making, whose views they tend to concur
with. This recourse to parental support was also observed by
health professionals conducting Meningitis ACWY vaccine catch-
up programmes in older adolescents and University students [46].
Independent health care decision-making in adolescence is
characterised as something that evolves over time and is depen-
dent on cognitive development, experience and the ability to com-
municate choices and understand options [47]. Hence, the
provision of health care services for young people requires ongoing
assessment of their developing autonomy which is not straightfor-
ward. There is a need for additional research, training and reflec-
tion about how to achieve this in order to help health
professionals gain more confidence in supporting adolescents in
the process of acquiring the necessary skills and information to
make immunisation and other health care-related decisions [48].
Ongoing research aimed at assessing the effectiveness of self-
consent and gaining insights into health professionals’ and adoles-
cents’ experiences of obtaining and providing self-consent will
contribute to this agenda [49].
5. Study limitations
This study provides insights into challenges and opportunities
in the implementation of adolescent immunisation programmes.
The use of different methods to gain insights has benefits but there
is a clear need for evidence about interventions aimed at improv-
ing programme logistics and consent practice. Our findings provide
descriptive and quantitative data to support the development of
interventions in England and Wales and similar settings. However,
we cannot draw any causal inference from the qualitative data
although the findings may be transferable in similar settings. The
cross-sectional survey results are more generalisable and this type
of attitudinal tracking is repeated at regular intervals by Public
Health England.
6. Conclusion
There is a need to streamline the logistics and enhance the prac-
tices involved in communicating information about adolescent
vaccination and obtaining consent for adolescents’ participation
in school-based immunisation programmes. Most young people
rely on parental guidance and resources should be provided to
stimulate discussion and enhance immunisation literacy. This
may increase adolescents’ capacity to make positive choices as
they gain more responsibility for their health. Health professionals
also need support in assessing and developing adolescent capacity
for making autonomous decisions about vaccination. We have
identified pathways that could contribute to improving the effec-
tiveness of the consent process. Many are currently being trialled
in small-scale studies in the UK and other countries. To ensure that
consenting does not reduce opportunities to vaccinate and lower
coverage in adolescent vaccines, we agree with Cooper et al. [41]
that there is need for further rigorous evaluation of interventions
in order to harness the potential efficiencies of school-based
programmes.
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